BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15838270)

  • 1. Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S160-4. PubMed ID: 15838270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of endothelin receptors in the brain of SHR-SP and effects of an endothelin blocker.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S156-9. PubMed ID: 15838268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of endothelin action normalizes altered levels of VEGF and its signaling in the brain of stroke-prone spontaneously hypertensive rat.
    Jesmin S; Maeda S; Mowa CN; Zaedi S; Togashi H; Prodhan SH; Yamaguchi T; Yoshioka M; Sakuma I; Miyauchi T; Kato N
    Eur J Pharmacol; 2007 Nov; 574(2-3):158-71. PubMed ID: 17689527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of endothelin and its receptors in the brain of SHR-SP at malignant hypertensive stage.
    Jesmin S; Sakuma I; Togashi H; Yamaguchi T; Ueno K; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S11-5. PubMed ID: 15838256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S59-63. PubMed ID: 15838360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
    Jesmin S; Zaedi S; Maeda S; Togashi H; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):919-24. PubMed ID: 16741024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats.
    Jesmin S; Hattori Y; Togashi H; Ueno K; Yoshioka M; Sakuma I
    Mol Cell Biochem; 2005 Apr; 272(1-2):63-73. PubMed ID: 16010973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit/hyperactivity disorder.
    Jesmin S; Togashi H; Sakuma I; Mowa CN; Ueno K; Yamaguchi T; Yoshioka M; Kitabatake A
    Endocrinology; 2004 Sep; 145(9):4330-43. PubMed ID: 15178644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats.
    Kubo T; Ibusuki T; Saito E; Kambe T; Hagiwara Y
    Eur J Pharmacol; 2000 Jul; 400(2-3):231-7. PubMed ID: 10988339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
    Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
    Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension.
    Suzuma I; Hata Y; Clermont A; Pokras F; Rook SL; Suzuma K; Feener EP; Aiello LP
    Diabetes; 2001 Feb; 50(2):444-54. PubMed ID: 11272159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
    Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M
    J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated basic fibroblast growth factor levels in stroke-prone spontaneously hypertensive rats.
    Lin TN; Wong YP; Chen JJ; Cheng JT; Yu SF; Sun SH; Chi SI; Chai CY
    Neuroscience; 1997 Jan; 76(2):557-70. PubMed ID: 9015338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP.
    Nakamura K; Sasaki S; Moriguchi J; Morimoto S; Miki S; Kawa T; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):876-82. PubMed ID: 10367590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats.
    Tostes RC; Touyz RM; He G; Ammarguellat F; Schiffrin EL
    J Cardiovasc Pharmacol; 2002 Jun; 39(6):892-900. PubMed ID: 12021584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP).
    Moniwa N; Agata J; Hagiwara M; Ura N; Shimamoto K
    Biol Chem; 2006 Feb; 387(2):203-9. PubMed ID: 16497153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular mitogen-activated protein kinase activity is enhanced via angiotensin system in spontaneously hypertensive rats.
    Kubo T; Ibusuki T; Saito E; Kambe T; Hagiwara Y
    Eur J Pharmacol; 1999 May; 372(3):279-85. PubMed ID: 10395023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670.
    Douglas SA; Gellai M; Ezekiel M; Feuerstein GZ; Elliott JD; Ohlstein EH
    Hypertension; 1995 Apr; 25(4 Pt 2):818-22. PubMed ID: 7721437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.